Tirzepatide (Injectable) in New London, CT
Doctor-prescribed Tirzepatide (Injectable) for New London residents. Reviewed by licensed Connecticut physicians, compounded at FDA-registered pharmacies, and shipped straight to your door in New London — no clinic visit required.
— All-in monthly price
No membership fee · this is the full price · free shipping · avg 4-week supply
available — pay over time at checkout— Add in-depth bloodwork
If your physician requires bloodwork and you don't have recent labs, an at-home panel is $129 — or get bloodwork done anywhere (your doctor, a lab, or insurance) and upload it — labs from the past 18 months work, at no charge.
Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.
This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.
About Tirzepatide (Injectable)
Dual GIP and GLP-1 receptor agonist offering enhanced weight management benefits.
How it works
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates both incretin pathways instead of just one. This dual action produces superior weight loss results vs semaglutide alone. Phase 3 trials showed up to 22.5% body weight loss.
Clinical evidence
The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) randomized 2,539 adults with obesity to tirzepatide 5/10/15 mg vs placebo. At 72 weeks, mean weight reductions were 15.0%, 19.5%, and 20.9% on the active arms vs 3.1% on placebo — the highest weight-loss outcomes recorded for a pharmacological intervention at the time. SURMOUNT-2 confirmed efficacy in patients with type 2 diabetes, and the SURPASS program (Frias et al., 2021) demonstrated superior HbA1c reduction vs semaglutide head-to-head. Tirzepatide's dual GIP+GLP-1 mechanism appears to drive both stronger appetite suppression and improved metabolic flexibility.
Benefits
How it works in New London
- Complete a free online intake (~5 minutes).
- A licensed Connecticut physician reviews your case within 24 hours.
- If approved, your prescription ships from our FDA-registered compounding pharmacy.
- Free shipping arrives in New London 2–4 business days later. Refills ship automatically when your supply runs out — cancel anytime.
Tirzepatide (Injectable) vs. Mounjaro / Zepbound
Compounded at an FDA-registered 503A pharmacy. Compounded medications are not FDA-approved.
Tirzepatide (Injectable) for New London patients
New London is in New London County and home to roughly 28K residents, about 43 miles southeast of Hartford. Pepti serves New London and the surrounding Connecticut area through licensed Connecticut physicians — and is available in all 50 states and Washington, D.C. Connecticut permits telehealth prescribing by Connecticut-licensed providers under state telehealth law. Online intake review establishes the provider-patient relationship for non-controlled medications.
New London sits in one of the fastest-growing GLP-1 telehealth markets in the country. Pepti brings that care to New London without a clinic visit — intake, physician review, and pharmacy fulfillment all happen online.
Dosing
Your prescribing physician determines the right dose, schedule, and how it's administered — based on your goals, medical history, and lab work. Your personalized protocol is provided after your consultation.
Important safety information
+
Possible side effects
Do not use if you have
If you experience severe side effects, call 911 or go to your nearest emergency room.
Frequently asked
in New London.
Can I get Tirzepatide (Injectable) prescribed in New London?
Yes. New London residents can get Tirzepatide (Injectable) prescribed online by a physician licensed in Connecticut, with no in-person visit. Your prescription is compounded at an FDA-registered pharmacy and shipped to New London. Connecticut permits telehealth prescribing by Connecticut-licensed providers under state telehealth law. Online intake review establishes the provider-patient relationship for non-controlled medications.
How long does delivery take to New London?
Orders ship from our FDA-registered compounding pharmacy within 1–3 business days of physician approval and typically arrive in New London 2–4 business days after shipment. Shipping is free to every New London address, and we deliver throughout New London County.
Do I need to visit a clinic in New London?
No. Pepti is fully telehealth — New London patients complete the entire process online, from intake to refills. Connecticut permits telehealth prescribing by Connecticut-licensed providers under state telehealth law. Online intake review establishes the provider-patient relationship for non-controlled medications.
How much does Tirzepatide (Injectable) cost in New London?
Tirzepatide (Injectable) starts at $179 at Pepti. Pepti is subscription-based — your refill ships when your supply runs out, and you can cancel anytime. Pricing is the same in New London as everywhere else — no city or Connecticut markup, and shipping is included.
Is Pepti available outside New London?
Yes — Pepti is available in all 50 states and Washington, D.C. Wherever you are in the country, a physician licensed in your state reviews your intake and your medication ships from an FDA-registered compounding pharmacy.
References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al.. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) · New England Journal of Medicine (2022) · PMID 35658024
- Garvey WT, Frias JP, Jastreboff AM, et al.. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2) · Lancet (2023) · PMID 37385275
- Frías JP, Davies MJ, Rosenstock J, et al.. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2) · New England Journal of Medicine (2021) · PMID 34170647
- Inagaki N, Takeuchi M, Oura T, et al.. Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono) · The Lancet Diabetes & Endocrinology (2022) · PMID 35468322
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Tirzepatide (Injectable) near New London
More peptide therapy in New London
More from Weight Loss
Pepti operates in New London, Connecticut through licensed physician partnerships. Compounded medications are produced at FDA-registered 503A pharmacies. Treatment decisions are made by your prescribing physician.
— Get started in New London
Ready to start Tirzepatide (Injectable) in New London?
Free assessment. Licensed Connecticut physicians. Money-back guarantee if not approved.